Product Comparison

Print

Email


McKesson #	1194022	1194021	1212567	1221601	1212568
Description	SKYRIZI® Risankizumab-rzaa 150 mg / mL Injection Prefilled Auto-Injector 1 mL	SKYRIZI® Risankizumab-rzaa 150 mg / mL Injection Prefilled Syringe 1 mL	SKYRIZI® Risankizumab-rzaa 60 mg / mL Injection Single-Dose Vial 10 mL	SKYRIZI® Risankizumab-rzaa 150 mg / mL Injection Single-Dose Prefilled Cartridge 1.2 mL	SKYRIZI® Risankizumab-rzaa 150 mg / mL Injection Single-Dose Prefilled Cartridge 2.4 mL
Manufacturer #	00074210001	00074105001	00074501501	0074106501	00074107001
Brand	SKYRIZI®	SKYRIZI®	SKYRIZI®	SKYRIZI®	SKYRIZI®
Manufacturer	AbbVie Inc	AbbVie Inc	AbbVie US LLC	AbbVie US LLC	AbbVie US LLC
Invoice	SKYRIZI, PEN 150MG/ML	SKYRIZI, PFS 150MG/ML	SKYRIZI, SDV 600MG/10ML D/S	SKYRIZI, INJ 180MG/1.2ML PF CARTRIDGE W/OBI D/S	SKYRIZI, INJ 360MG/2.4ML PF CARTRIDGE W/OBI D/S
	Log In to Order	Log In to Order	Log In to Order	Log In to Order	Log In to Order
Comparison
Container Type	Prefilled Auto-Injector	Prefilled Syringe	Single-Dose Vial	Single-Dose Prefilled Cartridge	Single-Dose Prefilled Cartridge
Country of Origin	Germany	Germany	United States	Germany	Germany
Generic Drug Code	49591	49617
NDC Number	00074210001	00074105001	00074501501	00074106501	00074107001
Strength	150 mg / mL	150 mg / mL	60 mg / mL	150 mg / mL	150 mg / mL
Type	Subcutaneous	Subcutaneous	Intravenous	Subcutaneous	Subcutaneous
UNSPSC Code	51241200	51241200	42142619	51241200	42142619
Volume	1 mL	1 mL	10 mL	1.2 mL	2.4 mL
Application	Monoclonal Antibody	Monoclonal Antibody	Monoclonal Antibody	Monoclonal Antibody	Monoclonal Antibody
Dosage Form	Injection	Injection	Injection	Injection	Injection
Generic Drug Name	Risankizumab-rzaa	Risankizumab-rzaa	Risankizumab-rzaa	Risankizumab-rzaa	Risankizumab-rzaa
Product Dating	McKesson Acceptable Dating: we will ship >= 180 days	McKesson Acceptable Dating: we will ship >= 180 days	McKesson Acceptable Dating: we will ship >= 180 days	McKesson Acceptable Dating: we will ship >= 180 days	McKesson Acceptable Dating: we will ship >= 180 days
Storage Requirements	Requires Refrigeration	Requires Refrigeration	Requires Refrigeration	Requires Refrigeration	Requires Refrigeration
Features and Benefits	SKYRIZI® is indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy Single-Dose Pen	SKYRIZI® is indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy Single-Dose Prefilled Syringe	SKYRIZI® is indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy SKYRIZI is indicated for the treatment of active psoriatic arthritis in adults SKYRIZI is indicated for the treatment of moderately to severely active Crohn's disease in adults 600 mg/10 mL (60 mg/mL) single-dose vial	SKYRIZI® is indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy 180 mg/1.2 mL (150 mg/mL) single-dose prefilled cartridge with on-body injector	SKYRIZI® is indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy SKYRIZI is indicated for the treatment of active psoriatic arthritis in adults SKYRIZI is indicated for the treatment of moderately to severely active Crohn's disease in adults 360 mg/2.4 mL (150 mg/mL) single-dose prefilled cartridge with on-body injector Store in a refrigerator at 36°F to 46° F (2°C to 8°C)

Product Comparison Comparison Options Print Email

Comparison

Product Comparison

Print

Email